Skip to main content
. 2016 Nov 29;8(1):1603–1612. doi: 10.18632/oncotarget.13688

Figure 3. Overall survival of normal karyotype MDS patients with CNVs detected by MLPA (median OS: 27 months) and patients without CNVs (median OS: 65 months).

Figure 3